NewEdge Wealth LLC purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 64,900 shares of the company’s stock, valued at approximately $8,340,000.
A number of other large investors have also recently made changes to their positions in MKGAF. Danske Bank A S purchased a new position in shares of Merck KGaA during the second quarter valued at approximately $276,535,000. Great Lakes Advisors LLC bought a new position in shares of Merck KGaA during the second quarter valued at approximately $183,444,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Merck KGaA in the second quarter worth $25,541,000. Diversify Advisory Services LLC purchased a new stake in Merck KGaA in the second quarter worth $3,810,000. Finally, Gables Capital Management Inc. purchased a new stake in Merck KGaA in the second quarter worth $2,095,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $167.38 on Thursday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm’s fifty day simple moving average is $162.50 and its 200 day simple moving average is $148.28. The stock has a market cap of $21.63 billion, a P/E ratio of 25.55 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
